A small retrospective study has linked BRAF mutations to worse 1-year and 2-year PFS rates in 60 dMMR CRC patients (40% vs. 73.3%, 26.7% vs. 73.3%; p < 0.001) [235]. The gene discussed is BRAF; the disease is colorectal carcinoma.